Continuation of treatment with blinded doses of crofelemer in the extension phase of the trial will support company's ...

Two publications from a 2026 randomized controlled trial add human evidence on fisetin supplement benefits, with implications for healthy aging, metabolic health, and inflammatory balance.

More research finds mixed results with adjunctive procedures in persistent atrial fibrilla ...

A five-week randomized controlled trial by UEA and Erasmus University found that "leisure crafting" raises workplace ...

H. Lundbeck A/S (Lundbeck) today announced that the last patient has been randomized in DEEp SEA (NCT06660394), a global Phase III clinical trial evaluating the efficacy, safety and tolerability of ...

But thromboembolic risks could be significant ...

Although percutaneous intervention for coronary artery disease is commonly performed before transcatheter aortic valve ...

Lutris Pharma, a clinical stage biopharmaceutical company focused on improving the quality of life and drug adherence for patients treated with anti-cancer therapies by mitigating dermatological ...

Introduction Parkinson’s disease (PD) is the second most common neurodegenerative disorder, its principal symptom being deterioration of motor function. Current treatment options are limited to ...

A systematic review and trial‐level meta‐analysis of randomized controlled trials assessed whether DFS predicts overall survival in localized RCC.

Antisecretory factor significantly reduced mortality in severe TBI patients in a phase II trial. Discover what this could ...

Both fractional doses of 17DD yellow fever vaccine were non-inferior to full doses in inducing initial seroconversion. The ...